AAN 2023: MS disability not worse for most on Kesimpta 5 years | Therapy for relapsing MS also shows good safety in new trial data
More than 80% of relapsing MS patients who took Kesimpta continuously for five years in a trial did not have any worsening of disability.
Source: multiplesclerosisnewstoday.com